Hot Topics in Rheumatoid Arthritis

Slideshow

Updates from the 2018 British Society for Rheumatology conference focus on RA treatment targets and resistance to biologics.

References1. Nikiphorou E, Norton S, Adam Young A, et al. Treating rheumatoid arthritis to target: is low disease activity good enough? Presented at: British Society for Rheumatology Annual Conference; May 1-3, 2018; Liverpool, UK.2. Kearsley-Fleet L, Watson K, Buch MH, et al. Refractory disease in rheumatoid arthritis: results from the British Society of Rheumatology Biologics Register for rheumatoid arthritis. Presented at: British Society for Rheumatology Annual Conference; May 1-3, 2018; Liverpool, UK.

Recent Videos
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
© 2024 MJH Life Sciences

All rights reserved.